Viriya Hantrakun
Contact information
Research groups
Viriya Hantrakun
Clinical Researcher
Melioidosis Epidemiology & Sepsis group
I am a lead clinical researcher in the melioidosis epidemiology & sepsis group under Associate Professor Direk Limmathurotsakul’s research group, Microbiology Department at MORU.
My PhD thesis includes the studies of environmental factors associated with the presence of Burkholderia pseudomallei, association between serological response to B. pseudomallei and an exposure to the organism and its closely related species (B. thailandensis), burden of melioidosis and Notifiable Diseases Surveillance System in Thailand. I am also a project coordinator and a contributor (database design) for www.melioidosis.info, which aims to generate evidence of melioidosis worldwide and to raise awareness about the burden of melioidosis among scientists, policy makers and the public.
More recently, I have started a study of the clinical epidemiology of community-acquired sepsis and the economic burden of neglected tropical diseases.
Recent publications
-
Effectiveness of a sepsis programme in a resource-limited setting: a retrospective analysis of data of a prospective observational study (Ubon-sepsis).
Booraphun S. et al, (2021), BMJ open, 11
-
Impact of low blood culture usage on rates of antimicrobial resistance.
Lim C. et al, (2020), The Journal of infection
-
Automating the Generation of Antimicrobial Resistance Surveillance Reports: Proof-of-Concept Study Involving Seven Hospitals in Seven Countries
Lim C. et al, (2020), Journal of Medical Internet Research, 22, e19762 - e19762
-
Lactoferrin is a dynamic protein in human melioidosis and is a TLR4-dependent driver of TNF-α release in Burkholderia thailandensis infection in vitro.
Wright SW. et al, (2020), PLoS neglected tropical diseases, 14
-
sTREM-1 predicts mortality in hospitalized patients with infection in a tropical, middle-income country.
Wright SW. et al, (2020), BMC medicine, 18